Compare PAMT & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAMT | GLSI |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.4M | 244.7M |
| IPO Year | 1995 | 2020 |
| Metric | PAMT | GLSI |
|---|---|---|
| Price | $12.50 | $15.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $13.00 | ★ $50.00 |
| AVG Volume (30 Days) | 15.3K | ★ 111.6K |
| Earning Date | 05-12-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $437,838,000.00 | N/A |
| Revenue This Year | $20.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.15 | N/A |
| 52 Week Low | $7.15 | $7.78 |
| 52 Week High | $17.75 | $34.10 |
| Indicator | PAMT | GLSI |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 43.48 |
| Support Level | $10.69 | $14.63 |
| Resistance Level | $13.04 | $29.89 |
| Average True Range (ATR) | 0.85 | 1.52 |
| MACD | 0.14 | -0.12 |
| Stochastic Oscillator | 67.26 | 14.94 |
PAMT Corp is a holding company that is engaged in providing truckload dry van carrier services transporting general commodities throughout the continental United States and Mexico, as well as in certain Canadian provinces. Its freight consists of automotive parts, expedited goods, consumer goods, such as general retail store merchandise, and manufactured goods, such as heating and air conditioning units. It has one reportable segment being motor carrier.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.